首页 | 本学科首页   官方微博 | 高级检索  
检索        

抗血小板聚积在慢性阻塞性肺病急性加重期的临床应用
引用本文:徐秀丽,康春萍,高路.抗血小板聚积在慢性阻塞性肺病急性加重期的临床应用[J].陕西医学杂志,2007,36(4):465-468.
作者姓名:徐秀丽  康春萍  高路
作者单位:1. 西安交通大学医学院第一附属医院急救中心,西安,710061
2. 西安铁路分局医院
摘    要:目的研究慢性阻塞性肺病急性加重期抗血小板聚积治疗对凝血系统、动脉血气分析、呼吸频率、心率的影响。方法慢性阻塞性肺病急性加重期患者93例,随机分为治疗组和对照组,治疗组除常规的抗感染、扩管、化痰、低流量吸氧等常规治疗外加丹奥静滴,对照组仅进行抗感染、扩管、化痰、低流量吸氧等常规治疗。比较治疗前和治疗后24h及72h两组凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、纤维蛋白原(FIB)等凝血因素的变化及动脉血气分析、呼吸频率、心率等。结果1治疗组治疗前,24h,72h各指标比较均有显著性差异(P<0.05)。2对照组治疗前,24h各指标比较均无显著性差异(P>0.05);24h,72h比较,PT、APTT、FIB、PaO2、PaCO2及R有显著性差异(P<0.05)。3治疗组治疗24h、72h与对照组治疗24h、72h相比,各指标比较均有显著性差异(P<0.05)。结论抗血小板聚积治疗在单位时间内能提高动脉血氧分压,降低动脉血二氧化碳分压,改善呼吸频率等有明显疗效。

关 键 词:肺疾病  慢性阻塞性/药物疗法  血小板聚集抑制剂/治疗应用  血气分析
修稿时间:2006-08-20

The effect of antiplatelet congestion in patients with chronic obstructive pulmonary disease exacerbation
Xu Xiuli,Kang Chunping,Gao Lu.The effect of antiplatelet congestion in patients with chronic obstructive pulmonary disease exacerbation[J].Shaanxi Medical Journal,2007,36(4):465-468.
Authors:Xu Xiuli  Kang Chunping  Gao Lu
Abstract:Objective: To study the effect of antiplatelet congestion on thromboxane system, arterial partial pressure of oxygen (PaO2), arterial partial pressure of carbon dioxide (PaCO2), respiratory rates (R),and heart rates (HR)in patients with chronic obstructive pulmonary disease exacerbation. Methods:Ninety three patients with chronic obstructive pulmonary disease exacerbation were divided into treatment group and control group randomly. The controls were treated by anti-infection, dilating blood vessel, eliminating phlegm and inhaling low concentration oxygen. Those in the study group were treated with Ozagrel in addition to above routine treatment. We explored the difference in plasma prothombin time (PT), activated partial thromboplastin time(APTT), fibrinogen(FIB), R, PaO2 and PaCO2 before therapy, 24 and 72 h after therapy. Results: There was significant difference in above index in treatment group between before therapy, 24 and 72 h after therapy(P<0.05). There was no significant difference in above index in control group between before therapy and 24 h after therapy(P>0.05), but there was significant difference in APTT,FIB,PaO2, PaCO2 and R between 24 and 72 h after therapy(P<0.05). There was significant difference in above index at 24 and 72 h after therapy between the treatment group and the control group (P<0.05). Conclusion: Antiplatelet congestion can significantly improve respiratory rates, PaO2 and PaCO2 in unit time.
Keywords:Pulmonary disease  chronic obstructive/drug therapy Platelet aggregation inhibitors/therapentic use Blood gas analysis
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号